Minerva Biotechnology and Biomolecular Research is an emerging journal published by EDIZIONI MINERVA MEDICA, dedicated to the fields of biotechnology, biomolecular research, and applied microbiology. With an ISSN of 2724-542X and an E-ISSN of 2724-5934, this journal aims to foster deeper understanding and innovative advancements in these rapidly evolving disciplines. The journal has been categorized in the Q4 quartile across four categories in the 2023 rankings, highlighting its nascent yet growing influence within the scientific community. Operating on an open-access model, it enhances accessibility and encourages the dissemination of knowledge to researchers, professionals, and students alike. Set in the heart of Italy, specifically at CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY, Minerva Biotechnology and Biomolecular Research will continue to enrich the scientific literature from its inception in 2021 through 2024 and beyond, contributing to the global dialogue on biotechnological innovations and molecular research.

European Journal of Histochemistry (ISSN: 1121-760X; E-ISSN: 2038-8306) is a distinguished peer-reviewed scholarly journal published by PAGEPRESS PUBL based in Italy. Since its inception in 1992 and with a commitment to Open Access since 2010, the journal has played a pivotal role in disseminating high-quality research in the fields of Histology, Biophysics, and Cell Biology. As of 2023, the journal holds a commendable position within the academic community, achieving Q2 rankings in Biophysics, Histology, and Medicine (miscellaneous), further highlighting its relevance and impact in these critical areas of research. Despite its HIndex not being specified, its Scopus rankings demonstrate the journal's competitive edge, particularly in Histology (Rank #33/62) and Biophysics (Rank #84/152). The journal aims to provide a platform for researchers to share innovative findings and contribute to the enrichment of knowledge in histochemical methodologies and their application to biomedical sciences. Its Open Access model ensures the broadest possible dissemination of research, making it an essential resource for researchers, professionals, and students alike who are engaged in the life sciences. For more information, visit the journal's webpage hosted by PAGEPRESS PUBL.

Theranostics is a premier journal in the field of Medicine and Pharmacology, published by IVYSPRING INT PUBL. With its commitment to open access since 2011, it facilitates the widespread dissemination of innovative research, fostering collaboration and advancements in therapeutic diagnostics. The journal proudly holds a Q1 ranking in both Medicine (Miscellaneous) and Pharmacology, Toxicology and Pharmaceutics, as of 2023, showcasing its esteemed position within the scientific community. Recognized globally, it ranks in the top 1%, with Scopus rankings placing it as 4th out of 398 in Medicine and 1st out of 43 in Pharmacology. Theranostics serves as a crucial platform for researchers, professionals, and students to explore cutting-edge developments as it converges multidisciplinary approaches to enhance patient care and treatment efficacy. With a focus on bridging experimental research and clinical applications, the journal is instrumental in shaping future therapies and diagnostic strategies.

Molecular Diagnosis & Therapy, published by ADIS INT LTD, is a premier journal dedicated to the cutting-edge fields of genetics, molecular medicine, and pharmacology. With a strong emphasis on the translation of molecular insights into innovative therapeutic strategies, this journal serves as a vital resource for researchers, clinicians, and students aiming to stay at the forefront of medical and scientific advancements. The journal boasts an impressive standing in its categories, holding a Q1 ranking in Genetics, Medicine (miscellaneous), and Pharmacology, alongside a Q2 classification in Molecular Medicine for 2023, reflecting its influential contributions to the scientific community. Indexed in Scopus, it occupies distinct positions in its respective fields, ranked #77 in Genetics and Pharmacology, and #53 in Molecular Medicine, highlighting its robust impact factor and scholarly influence. Although it is not open access, the journal ensures widespread dissemination of valuable research, promoting enhanced understanding of molecular diagnostic techniques and therapeutic interventions. Since its inception in 2001, and continuing through to 2024, Molecular Diagnosis & Therapy remains an essential platform for disseminating vital research findings, fostering academic collaboration, and driving forward the dialogue in molecular diagnostics and treatment methodologies.

HISTOCHEMISTRY AND CELL BIOLOGY, published by SPRINGER, is a prominent journal dedicated to advancing the fields of histochemistry and cell biology. With an ISSN of 0948-6143 and an E-ISSN of 1432-119X, this journal has carved a significant niche since its inception in 1995, striving for excellence in research dissemination through a rigorous peer-review process. The journal's impact is reflected in its strong performance across various academic categories, achieving a Q1 ranking in Medical Laboratory Technology, Q2 in Histology, and maintaining a credible presence in Cell and Molecular Biology. Nestled in Germany, and with the backing of a reputable publisher, HISTOCHEMISTRY AND CELL BIOLOGY serves as a pivotal platform for researchers, professionals, and students, fostering innovations that push the boundaries of our understanding of cellular processes. While the journal is not open access, it offers subscription-based access options ensuring comprehensive coverage of crucial findings in the rapidly evolving arena of cell biology and histochemistry.

Welcome to the JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, a premier platform for the dissemination of cutting-edge research in the fields of anatomy and histology. Published by SAGE PUBLICATIONS LTD, this esteemed journal has been a cornerstone of academic inquiry since its inception in 1953 and continues to play a vital role in advancing our understanding of cellular structure and function. With an impressive Impact Factor reflected in its rank as Q1 in both Anatomy and Histology categories, the journal ranks #5 out of 48 in Medicine Anatomy and #17 out of 62 in Medicine Histology, making it an essential resource for researchers and professionals alike. The journal provides a rigorous peer-review process and encourages submissions that enhance the scientific community's knowledge. As a vital resource for students, professionals, and researchers focusing on histochemical methodologies, the JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY offers insights into the latest advancements and critical debates within this dynamic discipline.

BIOMEDICAL PAPERS-OLOMOUC, published by Palacky University Medical Faculty, is a prominent open-access journal dedicated to advancing the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 2001, this journal has provided a vital platform for researchers, professionals, and students alike, fostering a collaborative environment for the dissemination of cutting-edge research findings. With a current impact factor reflected in its placement in the Q3 quartiles for both biochemistry and medicine categories, it demonstrates a growing influence in the academic community. The journal is indexed in Scopus, showcasing its relevance within the medical and biophysical sciences, and it operates in an open-access format to ensure broad accessibility of its articles. Set against the backdrop of Olomouc, Czech Republic, BIOMEDICAL PAPERS-OLOMOUC continues to contribute significantly to the global dialogue in biomedical research, making it an essential resource for anyone engaged in these dynamic and rapidly evolving fields.

Current Medical Science is a prominent academic journal dedicated to advancing knowledge in the fields of Medicine, Biochemistry, and Genetics. Published by SPRINGER with an ISSN of 2096-5230 and E-ISSN 2523-899X, this journal is based in China and serves as a vital resource for researchers, professionals, and students alike. With a focus on innovative research and emerging trends, Current Medical Science has established itself with an impactful presence, operating under Open Access guidelines to ensure wide dissemination of scientific findings. The journal's recognition is underscored by its impressive Scopus rankings, including a Q3 quartile placement in Biochemistry and Genetics as of 2023. It is noteworthy that the journal spans converged years from 2018 to 2024, providing a comprehensive platform for scholarly discussions and developments that drive the evolution of medical science. As it continues to publish influential research, Current Medical Science plays an essential role in bridging the gap between laboratory science and clinical application.

Protein & Cell, published by Oxford University Press, is a distinguished international journal focusing on cutting-edge research in the fields of biochemistry, biotechnology, cell biology, and drug discovery. This open access journal, active since 2014, is dedicated to disseminating innovative findings that advance our understanding of protein functions and cellular processes, making it an essential resource for researchers, professionals, and students alike. With an impressive 2023 impact factor reflected in its Q1 ranking across multiple categories such as Biochemistry, Drug Discovery, and Cell Biology, 'Protein & Cell' stands at the forefront of scientific research, driving collaboration and discussion in the scientific community. Researchers can access the journal freely online, fostering a global exchange of knowledge and contributing to significant advancements in medicine and biotechnology. Located in the United Kingdom, the journal strives to be a pivotal platform for impactful research that influences future studies and applications.

EBioMedicine is an esteemed open-access journal published by ELSEVIER, dedicated to advancing the fields of biochemistry, genetics, and molecular biology, as well as medicine. Since its inception in 2014, EBioMedicine has established itself as a prominent platform for disseminating high-quality research, evidenced by its impressive rankings in Scopus, where it holds a Q1 category in both Biochemistry, Genetics and Molecular Biology and Medicine for 2023. With an exceptional impact factor that places it in the top percentiles (97th in Medicine and 93rd in Biochemistry), the journal is recognized for its rigorous peer-review process and its commitment to fostering scientific collaboration. Open access since its launch, EBioMedicine ensures that groundbreaking research is readily available to researchers, professionals, and students worldwide, enhancing knowledge dissemination and driving innovation in these crucial fields. For those seeking to stay at the forefront of biomedical research, EBioMedicine is an invaluable resource.